AAAAAA

   
Results: 1-9 |
Results: 9
THE SUBSTANCE-P RECEPTOR ANTAGONIST L-754,030 (MK-0869) IS INEFFECTIVE IN THE TREATMENT OF POSTHERPETIC NEURALGIA
Authors: BLOCK GA RUE D PANEBIANCO D REINES SA
Citation: Ga. Block et al., THE SUBSTANCE-P RECEPTOR ANTAGONIST L-754,030 (MK-0869) IS INEFFECTIVE IN THE TREATMENT OF POSTHERPETIC NEURALGIA, Neurology, 50(4), 1998, pp. 4084-4084
PHARMACOKINETICS OF RIZATRIPTAN IN PATIENTS WITH MILD-MODERATE HEPATIC INSUFFICIENCY
Authors: GOLDBERG MR LEE Y PANEBIANCO D NOVECK RJ BRUCKER MJ MCLOUGHLIN DA OLAH TV SHADLE CR
Citation: Mr. Goldberg et al., PHARMACOKINETICS OF RIZATRIPTAN IN PATIENTS WITH MILD-MODERATE HEPATIC INSUFFICIENCY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 55-55
PILOT-STUDY OF MK-462 IN MIGRAINE
Authors: CUTLER NR CLAGHORN J SRAMEK JJ BLOCK G PANEBIANCO D CHENG H OLAH TV REINES SA
Citation: Nr. Cutler et al., PILOT-STUDY OF MK-462 IN MIGRAINE, Cephalalgia, 16(2), 1996, pp. 113-116
MK-462 IN MIGRAINE - A PILOT-STUDY
Authors: CUTLER NR CLAGHORN J SRAMEK JJ BLOCK G PANEBIANCO D CHENG H OLAH TV REINES SA
Citation: Nr. Cutler et al., MK-462 IN MIGRAINE - A PILOT-STUDY, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 32-32
EFFECT OF TOPICAL ENALAPRILAT (MK-422) IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE
Authors: SHEDDEN AH KRUPIN T FEITL M PANEBIANCO D VOGEL R
Citation: Ah. Shedden et al., EFFECT OF TOPICAL ENALAPRILAT (MK-422) IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE, Investigative ophthalmology & visual science, 36(4), 1995, pp. 823-823
PHARMACOKINETICS AND PHARMACODYNAMICS OF MK-383, A SELECTIVE NONPEPTIDE PLATELET GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST, IN HEALTHY-MEN/
Authors: BARRETT JS MURPHY G PEERLINCK K LEPELEIRE ID GOULD RJ PANEBIANCO D HAND E DECKMYN H VERMYLEN J ARNOUT J
Citation: Js. Barrett et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MK-383, A SELECTIVE NONPEPTIDE PLATELET GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST, IN HEALTHY-MEN/, Clinical pharmacology and therapeutics, 56(4), 1994, pp. 377-388
MK-383 (L-700,462), A SELECTIVE NONPEPTIDE PLATELET GLYCOPROTEIN-IIB IIIA ANTAGONIST, IS ACTIVE IN MAN/
Authors: PEERLINCK K DELEPELEIRE I GOLDBERG M FARRELL D BARRETT J HAND E PANEBIANCO D DECKMYN H VERMYLEN J ARNOUT J
Citation: K. Peerlinck et al., MK-383 (L-700,462), A SELECTIVE NONPEPTIDE PLATELET GLYCOPROTEIN-IIB IIIA ANTAGONIST, IS ACTIVE IN MAN/, Circulation, 88(4), 1993, pp. 1512-1517
4-WEEK SAFETY AND EFFICACY STUDY OF DORZOLAMIDE, A NOVEL, ACTIVE TOPICAL CARBONIC-ANHYDRASE INHIBITOR
Authors: WILKERSON M CYRLIN M LIPPA EA ESPOSITO D DEASY D PANEBIANCO D FAZIO R YABLONSKI M SHIELDS MB
Citation: M. Wilkerson et al., 4-WEEK SAFETY AND EFFICACY STUDY OF DORZOLAMIDE, A NOVEL, ACTIVE TOPICAL CARBONIC-ANHYDRASE INHIBITOR, Archives of ophthalmology, 111(10), 1993, pp. 1343-1350
THE SAFETY, OCULAR TOLERABILITY, AND IOP-LOWERING EFFECT OF A FIXED COMBINATION OF 0.5-PERCENT TIMOLOL AND 2.0-PERCENT MK-507 IN NORMAL SUBJECTS
Authors: STRAHLMAN ER ZIMMERMAN K CAMPBELL C FRILEY C PANEBIANCO D DEASY D LAIBOVITZ RA
Citation: Er. Strahlman et al., THE SAFETY, OCULAR TOLERABILITY, AND IOP-LOWERING EFFECT OF A FIXED COMBINATION OF 0.5-PERCENT TIMOLOL AND 2.0-PERCENT MK-507 IN NORMAL SUBJECTS, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1122-1122
Risultati: 1-9 |